{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:35:23Z","timestamp":1792784123771,"version":"4.5.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Italian Ministry of Health","award":["GR-2010- 2316745"],"award-info":[{"award-number":["GR-2010- 2316745"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jad-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.jad.2015.11.033","type":"journal-article","created":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T06:15:18Z","timestamp":1448950518000},"page":"187-208","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["A meta-analysis of efficacy and safety of aripiprazole in adult and pediatric bipolar disorder in randomized controlled trials and observational studies"],"prefix":"10.1016","volume":"191","author":[{"given":"Martina","family":"Meduri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Gregoraci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Baglivo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Balestrieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Isola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Brambilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2015.11.033_bib1","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1177\/0269881108098820","article-title":"A UK consensus on the administration of aripiprazole for the treatment of mania","volume":"23","author":"Aitchison","year":"2009","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jad.2015.11.033_bib2","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s40272-013-0016-6","article-title":"Weight gain and other metabolic adverse effects associated with atypical antipsychotic treatment of children and adolescents: a systematic review and meta-analysis","volume":"15","author":"Almandil","year":"2013","journal-title":"Paediatr. Drugs"},{"issue":"4","key":"10.1016\/j.jad.2015.11.033_bib4","first-page":"46","article-title":"Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials","author":"Anglemyer","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jad.2015.11.033_bib5","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.genhosppsych.2009.05.005","article-title":"Aripiprazole in major depression and mania: meta-analyses of randomized placebo-controlled trials","volume":"31","author":"Arbaizar","year":"2009","journal-title":"Gen. Hosp. Psychiatry"},{"key":"10.1016\/j.jad.2015.11.033_bib6","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/01.jcp.0000115665.45074.0d","article-title":"Which bias in antidepressant drug trials?","volume":"24","author":"Barbui","year":"2004","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2015.11.033_bib8","doi-asserted-by":"crossref","unstructured":"Biederman J., Mick E., Spencer T., Doyle R., Joshi G., Hammerness P., Kotarski M., Aleardi M. and Wozniak J., An open-label trial of aripiprazole monotherapy in children and adolescents with bipolar disorder, CNS Spectr. 12, 2007, 683\u2013689","DOI":"10.1017\/S1092852900021519"},{"key":"10.1016\/j.jad.2015.11.033_bib9","series-title":"Introduction to Meta-Analysis","author":"Borenstein","year":"2009"},{"key":"10.1016\/j.jad.2015.11.033_bib10","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1017\/S1461145701002668","article-title":"Perspectives on the use of anticonvulsants in the treatment of bipolar disorder","volume":"4","author":"Brambilla","year":"2001","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2015.11.033_bib11","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00213-002-1322-9","article-title":"Atypical antipsychotics and mood stabilization in bipolar disorder","volume":"166","author":"Brambilla","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jad.2015.11.033_bib12","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/00004850-200207000-00006","article-title":"Clozapine-treated subjects with resistant schizophrenia: a systematic review of experimental and observational studies","volume":"17","author":"Brambilla","year":"2002","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2015.11.033_bib13","first-page":"CD005000","article-title":"Aripiprazole alone or in combination for acute mania","volume":"12","author":"Brown","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jad.2015.11.033_bib14","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1124\/jpet.102.033175","article-title":"Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors","volume":"302","author":"Burris","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jad.2015.11.033_bib17","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/S0140-6736(11)60873-8","article-title":"Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis","volume":"378","author":"Cipriani","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jad.2015.11.033_bib18","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1001\/jama.2009.1549","article-title":"Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents","volume":"302","author":"Correll","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.jad.2015.11.033_bib19","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/S0140-6736(13)60855-7","article-title":"Genetics of bipolar disorder","volume":"381","author":"Craddock","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jad.2015.11.033_bib20","doi-asserted-by":"crossref","first-page":"827","DOI":"10.2165\/11584270-000000000-00000","article-title":"Aripiprazole in acute mania and long-term treatment of bipolar disorder: a critical review by an Italian working group","volume":"30","author":"De Fazio","year":"2010","journal-title":"Clin. Drug Investig."},{"key":"10.1016\/j.jad.2015.11.033_bib21","doi-asserted-by":"crossref","unstructured":"Dunn R.T., Stan V.A. and Chriki L.S., A prospective, open-label study of Aripiprazole mono- and adjunctive treatment in acute bipolar depression, J. Affect. Disord. 110, 2008, 70\u201374","DOI":"10.1016\/j.jad.2008.01.004"},{"key":"10.1016\/j.jad.2015.11.033_bib22","doi-asserted-by":"crossref","unstructured":"El Mallakh R.S., Vieta E., Rollin L., Marcus R., Carson W.H. and McQuade R., A comparison of two fixed doses of aripiprazole with placebo in acutely relapsed, hospitalized patients with bipolar disorder I (manic or mixed) in subpopulations (CN138-007), Eur. Neuropsychopharmacol. 20, 2010, 776\u2013783","DOI":"10.1016\/j.euroneuro.2010.07.003"},{"key":"10.1016\/j.jad.2015.11.033_bib23","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jad.2011.11.043","article-title":"A 40-week double-blind aripiprazole versus lithium follow-up of a 12-week acute phase study (total 52 weeks) in bipolar I disorder","volume":"136","author":"El-Mallakh","year":"2012","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2015.11.033_bib24","doi-asserted-by":"crossref","unstructured":"Findling R.L., Nyilas M., Forbes R.A., McQuade R.D., Jin N., Iwamoto T., Ivanova S., Carson W.H. and Chang K., Acute treatment of pediatric bipolar I disorder, manic or mixed episode, with aripiprazole: a randomized, double-blind, placebo-controlled study, J. Clin. Psychiatry 70, 2009, 1441\u20131451","DOI":"10.4088\/JCP.09m05164yel"},{"key":"10.1016\/j.jad.2015.11.033_bib27","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1744-859X-8-16","article-title":"Efficacy and safety of aripiprazole in the treatment of bipolar disorder: a systematic review","volume":"8","author":"Fountoulakis","year":"2009","journal-title":"Ann. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2015.11.033_bib28","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jad.2010.10.018","article-title":"Aripiprazole monotherapy in the treatment of bipolar disorder: a meta-analysis","volume":"133","author":"Fountoulakis","year":"2011","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2015.11.033_bib29","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1744-859X-8-27","article-title":"Treatment of psychotic symptoms in bipolar disorder with aripiprazole monotherapy: a meta-analysis","volume":"8","author":"Fountoulakis","year":"2009","journal-title":"Ann. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2015.11.033_bib30","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jclinepi.2005.06.006","article-title":"Imputing missing standard deviations in meta-analyses can provide accurate results","volume":"59","author":"Furukawa","year":"2006","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.jad.2015.11.033_bib31","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1517\/14656566.3.12.1773","article-title":"Aripiprazole: profile on efficacy and safety","volume":"3","author":"Goodnick","year":"2002","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.jad.2015.11.033_bib32","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.euroneuro.2008.03.003","article-title":"ECNP consensus meeting. Bipolar depression. Nice, March 2007","volume":"18","author":"Goodwin","year":"2008","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2015.11.033_bib33","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","year":"2011"},{"issue":"3","key":"10.1016\/j.jad.2015.11.033_bib34","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1177\/1740774508091600","article-title":"Imputation methods for missing outcome data in meta-analysis of clinical trials","volume":"5","author":"Higgins","year":"2008","journal-title":"Clin. Trials"},{"key":"10.1016\/j.jad.2015.11.033_bib35","doi-asserted-by":"crossref","unstructured":"Jeong H.G., Lee M.S., Ko Y.H., Han C. and Jung I.K., Combination treatment with aripiprazole and valproic acid for acute mania: an 8-week, single-blind, randomized controlled trial, Clin. Neuropharmacol. 35, 2012, 97\u2013102","DOI":"10.1097\/WNF.0b013e3182560401"},{"key":"10.1016\/j.jad.2015.11.033_bib36","doi-asserted-by":"crossref","unstructured":"Kanba S., Kawasaki H., Ishigooka J., Sakamoto K., Kinoshita T. and Kuroki T., A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole for the treatment of acute manic or mixed episodes in Asian patients with bipolar I disorder (the AMAZE study), World J. Biol. Psychiatry 15, 2012, 113\u2013121","DOI":"10.3109\/15622975.2012.669047"},{"key":"10.1016\/j.jad.2015.11.033_bib37","doi-asserted-by":"crossref","unstructured":"Keck P.E., Jr., Marcus R., Tourkodimitris S., Ali M., Liebeskind A., Saha A. and Ingenito G., A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania, Am. J. Psychiatry 160, 2003, 1651\u20131658","DOI":"10.1176\/appi.ajp.160.9.1651"},{"key":"10.1016\/j.jad.2015.11.033_bib38","doi-asserted-by":"crossref","unstructured":"Keck P.E., Orsulak P.J., Cutler A.J., Sanchez R., Torbeyns A., Marcus R.N., McQuade R.D. and Carson W.H., Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, double-blind, placebo- and lithium-controlled study, J. Affect. Disord. 112, 2009, 36\u201349","DOI":"10.1016\/j.jad.2008.05.014"},{"key":"10.1016\/j.jad.2015.11.033_bib39","first-page":"5","article-title":"Predictive value of early improvement in bipolar depression trials: a post-hoc pooled analysis of two 8-week aripiprazole studies","volume":"43","author":"Kemp","year":"2010","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.jad.2015.11.033_bib40","doi-asserted-by":"crossref","unstructured":"Marcus R., Khan A., Rollin L., Morris B., Timko K., Carson W. and Sanchez R., Efficacy of aripiprazole adjunctive to lithium or valproate in the long-term treatment of patients with bipolar I disorder with an inadequate response to lithium or valproate monotherapy: a multicenter, double-blind, randomized study, Bipolar Disord. 13, 2011, 133\u2013144 (CN 138-189)","DOI":"10.1111\/j.1399-5618.2011.00898.x"},{"key":"10.1016\/j.jad.2015.11.033_bib43","doi-asserted-by":"crossref","unstructured":"McElroy S.L., Suppes T., Frye M.A., Altshuler L.L., Stanford K., Martens B., Leverich G.S., Post R.M. and Keck P.E., Jr., Open-label aripiprazole in the treatment of acute bipolar depression: a prospective pilot trial, J. Affect. Disord. 101, 2007, 275\u2013281","DOI":"10.1016\/j.jad.2006.11.025"},{"key":"10.1016\/j.jad.2015.11.033_bib45","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1586\/14737175.7.8.919","article-title":"Maintenance treatment in bipolar disorder: a focus on aripiprazole","volume":"7","author":"McIntyre","year":"2007","journal-title":"Expert Rev. Neurother."},{"issue":"6","key":"10.1016\/j.jad.2015.11.033_bib46","article-title":"A 52-week, double-blind evaluation of the metabolic effects of aripiprazole and lithium in bipolar I disorder","volume":"13","author":"McIntyre","year":"2011","journal-title":"Prim. Care Companion CNS Disord."},{"key":"10.1016\/j.jad.2015.11.033_bib47","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s40263-013-0134-2","article-title":"Aripiprazole: a review of its use in the treatment of manic episodes in adolescents with bipolar I disorder","volume":"28","author":"McKeage","year":"2014","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jad.2015.11.033_bib48","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1517\/13543784.2014.971152","article-title":"Evaluating aripiprazole as a potential bipolar disorder therapy for adults","volume":"23","author":"Moro","year":"2014","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.jad.2015.11.033_bib49","unstructured":"NCT00223496, Bristol-Myers Squibb, 2013. 12-Week Open Label Treatment of Refractory Bipolar Depression, Clinical Trials Results Bristol-Myers Squibb. \u3008http:\/\/ ctr.bms.com\u3009."},{"key":"10.1016\/j.jad.2015.11.033_bib50","unstructured":"NCT00592683, Massachusetts General Hospital, 2012. Omega-3 Fatty Acid Adjunctive to Open-Label Aripiprazole for the Treatment of Bipolar Disorder in Children and Adolescents."},{"key":"10.1016\/j.jad.2015.11.033_bib51","unstructured":"NCT00665366, 2013 NCT00665366, Otsuka Pharmaceutical Development & Commercialization, 2013. Study to Evaluate the Efficacy and Safety of Aripiprazole Administered With Lithium or Valproate Over 12 Weeks in the Treatment of Mania in Bipolar I Disorder."},{"key":"10.1016\/j.jad.2015.11.033_bib52","unstructured":"NICE, Clinical Guideline 185, Issued: September 2014. Available from: \u3008www.guidance.nice.org.uk\/cg185\u3009."},{"key":"10.1016\/j.jad.2015.11.033_bib53","doi-asserted-by":"crossref","first-page":"509","DOI":"10.4088\/JCP.v67n0401","article-title":"Atypical antipsychotics in the treatment of mania: a meta-analysis of randomized, placebo-controlled trials","volume":"67","author":"Perlis","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2015.11.033_bib54","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/S0140-6736(13)60989-7","article-title":"Bipolar disorder diagnosis: challenges and future directions","volume":"381","author":"Phillips","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jad.2015.11.033_bib55","doi-asserted-by":"crossref","unstructured":"Quante A., Zeugmann S., Luborzewski A., Schommer N., Langosch J., Born C., Anghelescu I. and Wolf J., Aripiprazole as adjunct to a mood stabilizer and citalopram in bipolar depression: a randomized placebo-controlled pilot study, Hum. Psychopharmacol. 25, 2010, 126\u2013132","DOI":"10.1002\/hup.1096"},{"key":"10.1016\/j.jad.2015.11.033_bib56","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","article-title":"Including nonrandomized studies","author":"Reeves","year":"2008"},{"key":"10.1016\/j.jad.2015.11.033_bib57","doi-asserted-by":"crossref","unstructured":"Sachs G., Sanchez R., Marcus R., Stock E., McQuade R., Carson W., Abou-Gharbia N., Impellizzeri C., Kaplita S., Rollin L. and Iwamoto T., Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: a 3-week placebocontrolled study, J. Psychopharmacol. 20, 2006, 536\u2013546","DOI":"10.1177\/0269881106059693"},{"key":"10.1016\/j.jad.2015.11.033_bib58","doi-asserted-by":"crossref","unstructured":"Sajatovic M., Coconcea N., Ignacio R.V., Blow F.C., Hays R.W., Cassidy K.A. and Meyer W.J., Aripiprazole therapy in 20 older adults with bipolar disorder: a 12-week, openlabel trial, J. Clin. Psychiatry 69, 2008, 41\u201346","DOI":"10.4088\/JCP.v69n0106"},{"key":"10.1016\/j.jad.2015.11.033_bib59","first-page":"459","article-title":"When to start aripiprazole therapy in patients with bipolar mania","volume":"10","author":"Sayyaparaju","year":"2014","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.jad.2015.11.033_bib61","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1093\/aje\/kwm189","article-title":"Should meta-analyses of interventions include observational studies in addition to randomized controlled trials? A critical examination of underlying principles","volume":"166","author":"Shrier","year":"2007","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.jad.2015.11.033_bib63","series-title":"Massachusetts General Hospital Comprehensive Clinical Psychiatry","author":"Stern","year":"2015"},{"key":"10.1016\/j.jad.2015.11.033_bib64","doi-asserted-by":"crossref","unstructured":"Thase M.E., Jonas A., Khan A., Bowden C.L., Wu X., McQuade R.D., Carson W.H., Marcus R.N. and Owen R., Aripiprazole monotherapy in nonpsychotic bipolar I depression: results of 2 randomized, placebo-controlled studies, J. Clin. Psychopharmacol. 28, 2008, 13\u201320 (CN138-096 and CN138-146)","DOI":"10.1097\/jcp.0b013e3181618eb4"},{"key":"10.1016\/j.jad.2015.11.033_bib65","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0165-0327(00)00162-2","article-title":"A meta-analysis of the use of typical antipsychotic agents in bipolar disorder","volume":"65","author":"Tohen","year":"2001","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2015.11.033_bib66","doi-asserted-by":"crossref","unstructured":"Tramontina S., Zeni C.P., Ketzer C.R., Pheula G.F., Narvaez J. and Rohde L.A., Aripiprazole in children and dolescents with bipolar disorder comorbid with attention-deficit\/hyperactivity disorder: a pilot randomized clinical trial, J. Clin. Psychiatry 70, 2009, 756\u2013764","DOI":"10.4088\/JCP.08m04726"},{"key":"10.1016\/j.jad.2015.11.033_bib67","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s40263-013-0073-y","article-title":"Pharmacological management of bipolar depression: acute treatment, maintenance, and prophylaxis","volume":"27","author":"Vieta","year":"2013","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jad.2015.11.033_bib69","doi-asserted-by":"crossref","unstructured":"Vieta E., T'joen C., McQuade R.D., Carson W.H., Jr, Marcus R.N., Sanchez R., Owen R. and Nameche L., Efficacy of adjunctive aripiprazole to either valproate or lithium in bipolar mania patients partially nonresponsive to valproate\/lithium monotherapy: a placebo-controlled study, Am. J. Psychiatry 165, 2008, 1316\u20131325","DOI":"10.1176\/appi.ajp.2008.07101560"},{"key":"10.1016\/j.jad.2015.11.033_bib70","doi-asserted-by":"crossref","unstructured":"Vieta E., Bourin M., Sanchez R., Marcus R., Stock E., McQuade R., Carson W., Abou- Gharbia N., Swanink R. and Iwamoto T., 2005. Effectiveness of aripiprazole v. haloperidol in acute bipolar mania: double-blind, randomised, comparative 12-week trial, Br. J. Psychiatry 187, 2005, 235\u2013242","DOI":"10.1192\/bjp.187.3.235"},{"key":"10.1016\/j.jad.2015.11.033_bib71","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"335","author":"Von Elm","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.jad.2015.11.033_bib72","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1001\/jama.1996.03540040037030","article-title":"Cross-national epidemiology of major depression and bipolar disorder","volume":"276","author":"Weissman","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.jad.2015.11.033_bib74","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1399-5618.2009.00672.x","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009","volume":"11","author":"Yatham","year":"2009","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2015.11.033_bib75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/bdi.12025","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013","volume":"15","author":"Yatham","year":"2013","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2015.11.033_bib76","doi-asserted-by":"crossref","unstructured":"Young A.H., Oren D.A., Lowy A., McQuade R.D., Marcus R.N., Carson W.H., Spiller N.H., Torbeyns A.F. and Sanchez R., 2009. Aripiprazole monotherapy in acute mania: 12-week randomised placebo- and haloperidol-controlled study, Br. J. Psychiatry 194, 2009, 40\u201348","DOI":"10.1192\/bjp.bp.108.049965"},{"key":"10.1016\/j.jad.2015.11.033_bib77","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.urolonc.2006.12.001","article-title":"Meta-analysis in medical research: potentials and limitations","volume":"26","author":"Zwahlen","year":"2008","journal-title":"Urol. Oncol."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032715307758?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032715307758?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T23:29:40Z","timestamp":1567380580000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032715307758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":64,"alternative-id":["S0165032715307758"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2015.11.033","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A meta-analysis of efficacy and safety of aripiprazole in adult and pediatric bipolar disorder in randomized controlled trials and observational studies","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2015.11.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}